ArticleBlood advances2022

A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia.

Alessandro Broccoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.